Carcinoma, Non-Small-Cell Lung: all 6,641 studies

Page 59 of 67. Open to participants first (1,665), then studies with results posted, then the rest; newest registration first within each.

• Study Using WST11 in Patients With Obstructing Endobronchial Non-Small Cell Lung CancerTerminatedNCT00974662Phase 2
• A Study of the Safety and Pharmacology Of PI3-Kinase Inhibitor GDC-0941 In Combination With Either Paclitaxel And Carboplatin (With or Without Bevacizumab) or Pemetrexed, Cisplatin, And Bevacizumab in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00974584Phase 1
• DNA Chip Based Prognosis of Lung CancerCompletedNCT00973427
• Erlotinib Concurrent With Radiation Therapy in Non-small-cell Lung CancerStatus unknownNCT00973310Phase 2
• A Study In Patients Who Will Undergo Surgical Removal Of Non-Small Cell Lung Cancer To Evaluate Molecular Changes That Occur In Tumor Tissue After Short Term Exposure To PF-00299804TerminatedNCT00971191Phase 1
• Study Comparing EBUS & EUS to Mediastinoscopy in Staging and Detection of Lung CancerTerminatedNCT00970645Not applicable
• A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung CancerCompletedNCT00970580Phase 1
• 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid TumorsCompletedNCT00967577Phase 1
• Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT00964132Phase 2
• Evaluation of Preoperative Endobronchial Ultrasound (EBUS) in Non Small Cell Lung Cancer (NSCLC)CompletedNCT00960271
• A Study of Predictive and Prognostic Markers in Patients With Non-small Cell Lung CancerStatus unknownNCT00958555
• Epidemiologic Study of KRAS Mutation in Brazilian Patients With Advanced or Metastatic Non Small Cell Lung CancerCompletedNCT00956280
• Flaxseed Supplement in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Undergoing Chemotherapy and Radiation TherapyTerminatedNCT00955942Phase 1
• Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung CancerStatus unknownNCT00955695Phase 3
• Hypofractionated 3-Dimensional Radiation Therapy in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer. ICORG 99-09CompletedNCT00955175Phase 2
• Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung CancerCompletedNCT00954278Phase 1
• Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung CancerCompletedNCT00946673Phase 1
• Stereotactic Radiosurgery in Treating Patients Undergoing Chemotherapy and Radiation Therapy For Stage III Non-Small Cell Lung CancerCompletedNCT00945451Not applicable
• Hypofractionated Intensity Modulated Chemoradiotherapy to Treat Locally Advanced Non-Small Cell Lung CancerStatus unknownNCT00938418Phase 2
• Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung CancerTerminatedNCT00937482Phase 1
• Tarceva and AT-101 for Patients With Advanced Non-Small Cell Lung CancerWithdrawnNCT00934076Phase 1
• SORAVE - Sorafenib and Everolimus in Solid TumorsCompletedNCT00933777Phase 1
• Study to Evaluate SID 530 Compared to TaxotereCompletedNCT00931008Phase 3
• Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung CancerCompletedNCT00923884
• Effect of Talactoferrin in Adults With Non-Small Cell Lung CancerCompletedNCT00923741Phase 1
• Pemetrexed Plus Oxaliplatin as Adjuvant Chemotherapy for Radically Resected Non-Small Cell Lung CancerStatus unknownNCT00923637Phase 2
• Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)CompletedNCT00923312Phase 1/2
• Sorafenib Treatment in Non-Small Cell Lung Cancer After Failure of Epidermal Growth Factor Receptor-tyrosine Kinase InhibitorCompletedNCT00922584Phase 2
• Multicentre Study to Explore the Correlation Between Smoking Pattern and Clinical Efficacy of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Male PatientsCompletedNCT00922025
• Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic MalignanciesCompletedNCT00921739Phase 1
• Neoadjuvant or Adjuvant Chemotherapy in Patients With Operable Non-small-cell Lung CancerCompletedNCT00913705Phase 3
• Assessment of Video Assisted Thoracoscopic Surgery (VATS) Versus Open Surgery for Patients Undergoing LobectomyTerminatedNCT00912366
• Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor InhibitorsCompletedNCT00910676Phase 2
• Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy RegimenStatus unknownNCT00908336Phase 2
• Laboratory Study Using Samples From Patients With Non-Small Cell Lung Cancer Treated on Clinical Trial CASE-2507WithdrawnNCT00907699
• Study Of The Effect Of CP-751,871 In Combination With Gemcitabine And Cisplatin In Patients With Advanced Non-Small Cell Lung CancerWithdrawnNCT00907504Phase 3
• Pemetrexed and LBH589 in Patients With Advanced Non-Small Cell Lung CancerTerminatedNCT00907179Phase 1
• Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) PatientsStatus unknownNCT00906061Phase 2
• Biweekly Gemcitabine and Docetaxel as First Line Treatment for Advanced Disease in Elderly Non-Small Cell Lung Cancer (NSCLC) PatientsStatus unknownNCT00905983Phase 2
• Computed Tomography (CT) Perfusion Imaging of Lung CancerTerminatedNCT00905801Not applicable
• Abraxane and RT for Non-Small Cell Lung Cancer (NSCLC)WithdrawnNCT00903942Phase 2
• Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck CancerTerminatedNCT00901537Phase 1
• Epidermal Growth Factor Receptor Mutations in the Blood of Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00899756
• Blood Samples From Patients With Non-Small Cell Lung Cancer and From Healthy VolunteersCompletedNCT00897234
• Everolimus and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis From Non-Small Cell Lung CancerTerminatedNCT00892801Phase 1
• Study of Pemetrexed Versus Gefitinib in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy Without Epidermal Growth Factor Receptor (EGFR) MutationsCompletedNCT00891579Phase 2
• Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC)CompletedNCT00890903
• Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung CancerCompletedNCT00888823Phase 1/2
• A Study of Pemetrexed Plus Carboplatin Combined With Radiation in Patients With Inoperable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (RT0801)Status unknownNCT00886678Phase 2
• Concurrent Chemotherapy and Radiotherapy With Nitroglycerin in Patients With Locally Advanced Non-Small Cell Lung CancerStatus unknownNCT00886405Phase 2
• A Study of Oral Sapacitabine in Patients With Previously Treated Non-Small Cell Lung CancerTerminatedNCT00885963Phase 2
• Individualized Treatment Based on Epidermal Growth Factor Receptor Mutations and Level of BRCA1 Expression in Advanced AdenocarcinomaCompletedNCT00883480Not applicable
• Gemcitabine and Carboplatin for Elderly Patient With Lung CancerCompletedNCT00881296Phase 2
• Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung CancerCompletedNCT00880971Phase 3
• Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung CancerWithdrawnNCT00880386Not applicable
• EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC)CompletedNCT00879866Phase 1
• Proton Therapy for Stage I Non-Small Cell Lung Cancer (LU03)CompletedNCT00875901Not applicable
• Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung CancerCompletedNCT00874588Phase 1
• Erlotinib Versus Gemcitabine/Carboplatin in Chemo-naive Stage IIIB/IV Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Exon 19 or 21 MutationCompletedNCT00874419Phase 3
• A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)Status unknownNCT00874328Phase 1/2
• Efficacy/Safety of Imprime PGG® Injection With Bevacizumab and Paclitaxel/Carboplatin in Patients With Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00874107Phase 2
• A Study of Nimotuzumab in Combination With Radiation Therapy in Patients With Brain MetastasesTerminatedNCT00872482Phase 2
• Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00870532Phase 1
• Stereotactic Body Radio Therapy (SBRT) for Early-stage Non Small Cell Lung Cancer (NSCLC)Status unknownNCT00870116Not applicable
• Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung CancerCompletedNCT00866528Phase 1
• Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lung Cancer (NSCLC)CompletedNCT00865319Phase 2
• Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and ChemotherapyCompletedNCT00864331Phase 3
• Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung CancerCompletedNCT00864266Not applicable
• Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)CompletedNCT00864110Phase 1
• Gene-expression Profiles in CNS-metastatic Non-small Cell Lung CancerStatus unknownNCT00862173
• CT-Based Versus Conventional Simulation for Palliative Radiotherapy of Non-Small Cell Lung CancerCompletedNCT00862030
• Video-assisted Thoracoscopic Surgery for Stage IIIA Non-Small Cell Lung CancerStatus unknownNCT00862004Phase 2
• Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin for Non-Small Cell Lung Cancer With KRAS or EGFR ActivationCompletedNCT00861627Phase 2
• Endobronchial Ultrasound Guided Transbronchial Needle Aspiration (EBUS-TBNA) for Mediastinal Re-staging of Non-small Cell Lung Cancer(NSCLC)WithdrawnNCT00859742Not applicable
• Beta-Glucan in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT00857025Phase 1
• Autologous Tumor DRibble Vaccine in Patients With Non-Small Cell Lung CancerCompletedNCT00850785Phase 1
• Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung CancerTerminatedNCT00850577Phase 2
• Study of Concurrent Pemetrexed, Cisplatin and Radiotherapy in Local Advanced Non-Small Cell Lung CancerStatus unknownNCT00846443Phase 1
• Vibration Response Imaging (VRI) in the Preoperative Management in Patients With Non-Small Cell Lung CancerStatus unknownNCT00845143
• Study of Erlotinib With Docetaxel in Selected Non Small Cell Lung Cancer Patients in First Line TreatmentCompletedNCT00840125Phase 2
• 2nd Line Erlotinib Treatment With (Out) Chemotherapy of Advanced Non Small Cell Lung Cancer (NSCLC)CompletedNCT00835471Phase 2
• Utility of Endobronchial Ultrasound Guided Needle Biopsy in Early Stage Non- Small Cell Lung Cancer (NSCLC)CompletedNCT00832715Phase 1/2
• Phase II Study of DMXAA (ASA404) in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00832494Phase 1/2
• Epidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLINCompletedNCT00831909
• Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)CompletedNCT00831545Phase 2
• Identification of EGFR-TKIs Sensitivity or Resistance Markers in NSCLC May Help in Optimal Patient SelectionCompletedNCT00831454
• A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung CancerTerminatedNCT00830245Phase 2
• Modafinil for the Treatment of Fatigue in Lung Cancer V9.0CompletedNCT00829322Phase 4
• Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung CancerStatus unknownNCT00828022Phase 1/2
• An Open-Label Study of QD Oral Administration of Tivozanib (AV-951) in Subjects With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00826878Phase 1
• Detection of Circulating Endothelial Progenitors Cells (EPCs) in Non-small Cell Lung Cancer (NSCLC)CompletedNCT00826683Phase 3
• Topical Cyclosporine vs. Placebo for Epiphora Associated With DocetaxelWithdrawnNCT00824811Phase 2
• Trial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00819728Phase 2
• Stereotactic Body Radiation Therapy (SBRT) as a Boost After Definitive Concurrent Chemoradiation (ChemoRT) for Non-Small Cell Lung Cancer (NSCLC) GCC 0516WithdrawnNCT00818714Phase 1
• A Study of Ridaforolimus in Non-Small Cell Lung Cancer (NSCLC) Patients With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutations (MK-8669-021 AM1)TerminatedNCT00818675Phase 2
• The Method ISET (Insulation by Size of Epithelial Tumor Cells)CompletedNCT00818558Not applicable
• Non-small Cell Lung Cancer and Quality of LifeCompletedNCT00818402
• A Phase II Study of TX Regimen as First-line Treatment for Asian Elderly Patients With Advanced Adenocarcinoma of LungCompletedNCT00816868Phase 2
• Mutations in the Epidermal Growth Factor Receptor(EGFR) Gene in Non-Small Cell Lung Carcinoma (NSCLC) and the Relation to Response of Treatment With ErlotinibStatus unknownNCT00815971
• Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC)Status unknownNCT00813332Phase 4

← Carcinoma, Non-Small-Cell Lung overview